Passage Bio (PASG.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov11

Passage Bio released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.4399 (forecast USD -2.84)

04:00

Passage Bio released FY2025 9 Months Earnings on November 10 (EST), actual revenue USD 0, actual EPS USD -10.3598

04:00

Oct14

Passage Bio Announces CEO and President Transition

12:03

Aug13

Passage Bio released FY2025 Semi-Annual Earnings on August 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -7.8289

03:00

Aug12

Passage Bio released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.9615 (forecast USD -4.04)

15:00

Jun26

OrbiMed Advisors LLC Reports Sale of Passage Bio Inc. Common Stock

21:11

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.749 M, EPS -2.4377

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -9.385 M, EPS -2.9615

Jul14

Reverse Stock Split(EST)

1-for-20 Reverse Stock Split

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More